Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 525 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 525 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 481-500 of 525 trials

UnknownASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing TaxotereThe purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays or limits disease progression and is safe with minimal side effects.NCT00043576·Montgomery, Alabama and 61 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedZoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneRATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases.NCT00003884·Birmingham, Alabama and 54 others

Active not recruitingSubstudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)Substudy 01A is part of a larger research study that is testing experimental treatments for metastatic castration-resistant prostate cancer (mCRPC).NCT06353386·La Jolla, California and 76 others

TerminatedEfficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)This study will assess the efficacy and safety of pembrolizumab plus enzalutamide plus Androgen Deprivation Therapy (ADT) versus placebo plus enzalutamide plus ADT in participants…NCT04191096·Anchorage, Alaska and 233 others

CompletedGemcitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00276549·Cleveland, Ohio

CompletedObservational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerObservational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer…NCT02141438·Anchorage, Alaska and 67 others

Active not recruitingONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPCIn this Phase 2 study, mCRPC patients with PSMA positive scans who progressed on prior ARTA and up to 2 lines of taxanes, and are naïve to lutetium Lu 177 vipivotide tetraxetan…NCT05682443·Sacramento, California and 22 others

RecruitingA Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate CancerThe purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of Pasritamig in combination with JNJ-86974680 in Part 1 (Dose finding) of the study and…NCT07319871·Sarasota, Florida and 4 others

TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

CompletedImaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.A prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA) 7.3…NCT04186819·Birmingham, Alabama and 33 others

CompletedA Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.The purpose of the study is to assess if the addition of darolutamide to ADT compared with ADT alone would result in superior clinical efficacy in participants with metastatic…NCT05059236·Homewood, Alabama and 30 others

TerminatedMRI Before Biopsy in Diagnosing Patients With Prostate CancerThis pilot clinical trial studies how well magnetic resonance imaging (MRI) before biopsy works in diagnosing patients with prostate cancer.NCT02131207·Cleveland, Ohio

RecruitingA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerThis study will test whether BNT324 is safe and works better against metastatic castration-resistant prostate cancer (mCRPC) than the current standard of care (SoC) chemotherapy…NCT07365995·Santa Barbara, California and 51 others

CompletedObservational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management.NCT02380274·Homewood, Alabama and 147 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

CompletedProstate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic…NCT00106691·Huntsville, Alabama and 137 others

TerminatedInformed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach ProgramThis clinical trial studies an informed decision making intervention of screening for prostate cancer in predominantly African American participants.NCT02419846·Cleveland, Ohio

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

RecruitingBarrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialBarrigel is intended to temporarily position the anterior rectal wall away from the prostate or prostate bed during radiotherapy treatment for prostate cancer and, in creating…NCT06496256·Chandler, Arizona and 12 others

Active not recruitingCapivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN DeficiencyThis study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone…NCT04493853·Tucson, Arizona and 322 others

PreviousPage 25 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma